Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex - PubMed (original) (raw)
Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex
Gail Ishiyama et al. Acta Otolaryngol. 2006 Oct.
Abstract
Conclusions: Gentamicin ototoxicity presents with gait imbalance and oscillopsia, but only rarely with hearing loss and vertigo. Sinusoidal rotational stimuli with high accelerations such as the bedside head-thrust test or rotational step changes in velocity are useful to diagnose bilateral vestibulopathy.
Objective: To describe the salient clinical features and vestibular testing results in gentamicin ototoxicity.
Patients and methods: A retrospective review of the quantitative vestibular function testing results for patients presenting to the UCLA Neurotology Clinic with gentamicin ototoxicity over the past 10 years (n=35).
Results: All patients presented with imbalance and 33 out of 35 had oscillopsia. Three patients reported a noticeable change in hearing and five reported vertigo. Of the 35 patients, 15 were in renal failure at the time of gentamicin administration. Patients with pre-existing peripheral neuropathy compensated poorly. Sinusoidal rotational testing demonstrated profoundly decreased gain and increased phase lead over the entire frequency range, with a subset of patients having relatively preserved gain at the intermediate frequencies (0.8-1.6 Hz) and low acceleration (<30 degrees/s). There was little or no response to high acceleration step changes in velocity. The time constant measured both by sinusoidal and step responses was ultra-low. All patients tested had a positive head-thrust test bilaterally.
Similar articles
- The clinical utility of search coil horizontal vestibulo-ocular reflex testing.
Kessler P, Zarandy MM, Hajioff D, Tomlinson D, Ranalli P, Rutka J. Kessler P, et al. Acta Otolaryngol. 2008 Jan;128(1):29-37. doi: 10.1080/00016480701299642. Acta Otolaryngol. 2008. PMID: 17851913 - Horizontal head impulse test detects gentamicin vestibulotoxicity.
Weber KP, Aw ST, Todd MJ, McGarvie LA, Curthoys IS, Halmagyi GM. Weber KP, et al. Neurology. 2009 Apr 21;72(16):1417-24. doi: 10.1212/WNL.0b013e3181a18652. Neurology. 2009. PMID: 19380701 - Changes in the human vestibulo-ocular reflex after loss of peripheral sensitivity.
Baloh RW, Honrubia V, Yee RD, Hess K. Baloh RW, et al. Ann Neurol. 1984 Aug;16(2):222-8. doi: 10.1002/ana.410160209. Ann Neurol. 1984. PMID: 6476793 - Bilateral vestibulopathy revisited.
Brandt T. Brandt T. Eur J Med Res. 1996 May 24;1(8):361-8. Eur J Med Res. 1996. PMID: 9360934 Review. - [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review].
Pino Rivero V, Marcos García M, Keituqwa Yáñez T, González Palomino A, Trinidad Ruiz G, Pardo Romero G, Blasco Huelva A. Pino Rivero V, et al. An Otorrinolaringol Ibero Am. 2004;31(6):531-7. An Otorrinolaringol Ibero Am. 2004. PMID: 15663084 Review. Spanish.
Cited by
- Development and Content Validity of the Bilateral Vestibulopathy Questionnaire.
van Stiphout L, Hossein I, Kimman M, Whitney SL, Ayiotis A, Strupp M, Guinand N, Pérez Fornos A, Widdershoven J, Ramos-Macías Á, Van Rompaey V, van de Berg R. van Stiphout L, et al. Front Neurol. 2022 Mar 17;13:852048. doi: 10.3389/fneur.2022.852048. eCollection 2022. Front Neurol. 2022. PMID: 35370880 Free PMC article. - A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides?
Ibekwe TS, Bhimrao SK, Westerberg BD, Kozak FK. Ibekwe TS, et al. Afr J Paediatr Surg. 2015 Apr-Jun;12(2):105-13. doi: 10.4103/0189-6725.160342. Afr J Paediatr Surg. 2015. PMID: 26168747 Free PMC article. Review. - The bedside assessment of vertigo.
Kaski D, Seemungal BM. Kaski D, et al. Clin Med (Lond). 2010 Aug;10(4):402-5. doi: 10.7861/clinmedicine.10-4-402. Clin Med (Lond). 2010. PMID: 20849021 Free PMC article. Review. No abstract available. - Identification of a series of hair-cell MET channel blockers that protect against aminoglycoside-induced ototoxicity.
Kenyon EJ, Kirkwood NK, Kitcher SR, Goodyear RJ, Derudas M, Cantillon DM, Baxendale S, de la Vega de León A, Mahieu VN, Osgood RT, Wilson CD, Bull JC, Waddell SJ, Whitfield TT, Ward SE, Kros CJ, Richardson GP. Kenyon EJ, et al. JCI Insight. 2021 Apr 8;6(7):e145704. doi: 10.1172/jci.insight.145704. JCI Insight. 2021. PMID: 33735112 Free PMC article. - Aminoglycoside ototoxicity: Vestibular function is also vulnerable.
Seemungal BM, Bronstein AM. Seemungal BM, et al. BMJ. 2007 Nov 10;335(7627):952. doi: 10.1136/bmj.39388.451019.1F. BMJ. 2007. PMID: 17991943 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous